Filing Details
- Accession Number:
- 0001209191-15-005333
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-20 21:00:34
- Reporting Period:
- 2015-01-16
- Filing Date:
- 2015-01-20
- Accepted Time:
- 2015-01-20 21:00:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1463729 | Receptos Inc. | RCPT | Pharmaceutical Preparations (2834) | 264190792 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1553179 | Waage Christian | 3033 Science Park, Suite 300 San Diego CA 92121 | Svp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-09-16 | 25,000 | $22.65 | 25,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-09-16 | 25,000 | $107.05 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-01-16 | 25,000 | $0.00 | 25,000 | $22.65 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
125,000 | 2023-11-24 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.33 to $110.78 per share, inclusive. The reporting person undertakes to provide to Receptos, Inc., any security holder of Receptos, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The option, representing a right to purchase a total of 150,000 shares, became exercisable as follows: 25% on the one-year anniversary of November 25, 2013 and 1/48th of the shares vest each month thereafter for the remaining three years. The option is subject to vesting acceleration in the event of certain corporate or change of control transactions.